|
|
Volumn 59, Issue 21, 2002, Pages 2046-2047
|
|
Antisense drugs progressing through product pipelines
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTISENSE OLIGONUCLEOTIDE;
AVI 4126;
CARDIOLIPIN;
FOMIVIRSEN;
INTERCELLULAR ADHESION MOLECULE 1;
LERAFAON;
LIPOSOME;
OBLIMERSEN;
PROTEIN BCL 2;
RAF PROTEIN;
UNCLASSIFIED DRUG;
ACUTE GRANULOCYTIC LEUKEMIA;
CLINICAL TRIAL;
CYTOMEGALOVIRUS INFECTION;
DRUG APPROVAL;
DRUG INDICATION;
DRUG RESEARCH;
FOOD AND DRUG ADMINISTRATION;
GENE TECHNOLOGY;
HUMAN;
MULTIPLE MYELOMA;
MYELOMA;
NOTE;
ONCOGENE C MYC;
PRIORITY JOURNAL;
PSORIASIS;
ULCERATIVE COLITIS;
UNITED STATES;
|
|
EID: 0036828956
PISSN: 10792082
EISSN: None
Source Type: Journal
DOI: 10.1093/ajhp/59.21.2046 Document Type: Note |
|
Times cited : (3)
|
|
References (0)
|